Abstract
Critical pathways are predefined protocols that define the crucial steps in evaluating and treating a clinical problem to improve quality of patient care, reduce variability and enhance efficiency. Critical pathways have proliferated for a variety of diagnoses, including evaluation of patients with chest pain, a common and costly complaint. This review will outline the development, implementation, and assessment of critical pathways using as a paradigm our experience with a pathway for patients presenting to the Emergency Department with acute chest pain who are at low risk of myocardial ischemia. The goals of the pathway were to expedite evaluation of low-risk patients and reduce admission rates among these patients and in the cohort overall without compromising outcomes.
The pathway was developed by a multidisciplinary team in an iterative process that considered published literature, as well as the experience and consensus of local opinion leaders. Patients at least 30 years old presenting to the Emergency Department of an urban teaching hospital who were pain-free without heart failure or ischemic changes on EKG, but who were not considered appropriate for discharge by the treating physician, were eligible for the critical pathway. The pathway involved one set of creatine kinase-MB enzymes drawn at least 4 hours after pain, a 6 hour observation period after the last episode of pain and exercise testing. Outcomes during evaluation and admission rates were assessed. Clinical outcomes at 7 days and 6 months after evaluation and patient satisfaction at 7 days were also measured.
Of 1363 patient visits, 145 (10.6%) were triaged by the pathway: 131 (90.3%) were discharged, 14 (9.7%) were admitted. The overall admission rate decreased from 63% (2898/4595) to 60% (819/1363) [p < 0.05] in comparison to a cohort studied prior to pathway implementation. Pathway patients reported low rates of subsequent cardiac procedures. No deaths or myocardial infarctions were recorded. At 7 days, only 2 respondents (2%) reported going to an Emergency Department since their evaluation. Most respondents (83%) rated their care as very good or excellent.
Critical pathways designed to enhance efficiency, reduce variability, and improve the quality of care are becoming increasingly common. Our pathway for evaluation of patients with chest pain at low risk of myocardial ischemia was feasible and safe and was associated with a decline in absolute admission rates. Because of the possibility of concomitant secular trends and the effects of a changing medical environment, further rigorous research on the efficacy of individual pathways is needed.
Similar content being viewed by others
References
Every NR, Hochman J, Becker R, et al. Critical path-ways: a review (AHA Scientific Statement). Circulation2000;101:461–465.
Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med1995;123:941–948.
Schoenenberger RA, Pearson SD, Goldhaber SZ, Lee TH. Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway. Am J Med 1996;100:278–282.
Velasco FT, Ko W, Rosengart T, et al. Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York Hospital—Cornell Medical Center. Best Pract Benchmarking Healthc1996;1:21–28.
Cannon CP, Johnson EB, Cermignani M, et al. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction. Clin Cardiol1999;22:17–20.
Pearson SD, Lee TH, McCabe-Hassan S, Dorsey JL, Goldhaber SZ. A critical pathway to treat proximal lower-extremity deep vein thrombosis. Am J Med1996;100:283–289.
Pearson SD, Kleefield SF, Soukop JR, Cook EF, Lee TH. Critical pathways intervention to reduce length of stay. Am J Med 2001;110:175–180.
Nichol G, Walls R, Goldman L, et al. A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact. Ann Intern Med1997;127:996–1005.
Cannon CP. Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/nonST-segment elevation myocardial infarction. Clin Cardiol1999;22:IV30–IV36.
Ng SM, Krishnaswamy P, Morissey R, et al. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol2001;88:611–617.
Fleischmann KE, Lee TH. Critical pathways for evaluating the chest pain patient at low risk. In: Cannon CP, O'Gara PT, Eds. Critical Pathways in Cardiology. Philadelphia: Lippincott Williams & Wilkins, 2001:29–33.
deFillipi CR, Runge MS. Evaluating the chest pain patient. Cardiology Clinics1999;2:307–326.
McCaig LF. National hospital ambulatory medical care survey: 1992 emergency department summary. Advance data No. 245, 1994.
Ryan RJ. Refining the classification of chest pain: a logical next step in the evaluation of patients for acute cardiac ischemia in the Emergency Department. Ann Emerg Med1997;29:166.
Goldman L, Cook EF, Brand DA, et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med1988;318:797–803.
Goldman L, Cook EF, Johnson PA, et al. Prediction of the need for intensive care in patients who come to Emergency Departments with acute chest pain. N Engl J Med1996;334:1498–1504.
Weingarten S, Ermann B, Bolus R, et al. Early “step-down” transfer of low-risk patients with chest pain. A controlled interventional trial Ann Intern Med1990;113:283–289.
Weingarten S, Riedlinger MS, Conner L, et al. Practice guidelines and reminders to reduce duration of hospital stay for patients with chest pain. An interventional trial. Ann Intern Med1994;120:257–263.
Hamm C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med1997;337:1648–1653.
Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase-MB to “rule-out” acute myocardial infarction. N Engl J Med1994;331:561–566.
Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol1998;32:8–14.
Lewis WR, Amsterdam EZ. Utility and safety of immediate exercise testing of low-risk patients admitted to the hospital for suspected acute myocardial infarction. Am J Cardiol1994;74:987–990.
Gaspoz JM, Lee TH, Weinstein MC, et al. Cost-effectiveness of a new short-stay unit to “rule-out” acute myocardial infarction in low risk patients. J Am Coll Cardiol1994;24:1249–1259.
Gibler WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med1995;25: 1–8.
Gomez MA, Anderson JL, Karagounis LA, et al. An emergency department based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol1996;28:25–33.
Roberts RR, Zalenski RJ, Mensah EK, et al. Costs of an Emergency Department based accelerated diagnostic protocol vs hospitalization in patients with chest pain. JAMA1997;278:1670–1676.
Braunwald E, Mark D, Jones R, et al. Unstable angina: diagnosis and management. In: Clinical Practice Guideline No. 10, AHCPR Publ No. 940602, PHS, US. DHH Services. Rockville: AHCPR and the NHLBI. 1994.
Lee TH, Juarez G, Cook EF, et al. Ruling out acute myocardial infarction: a prospective validation of a 12 hour strategy for patients at low risk. N Engl J Med1991;324:1239–1246.
Fleischmann KE, Goldman L, Robiolio PA, et al. Echocardiographic correlates of survival in patients with chest pain. JACC1994;23:1390–1396.
Fleischmann KE, Lee TH, Come PC, et al. Echocardiographic prediction of complications in patients with chest pain. American Journal of Cardiology1997;79:292–298.
Burstin HR, Conn A, Setnik G, et al. Benchmarking and quality improvement: the Harvard Emergency Department Quality Study. American Journal of Medicine1999;107(5):437–439.
Polanczyk C, Goldman L, Johnson PA, et al. Clinical correlates and prognostic significance of early negative exercise tests in patients with acute chest pain. Am J Cardiol1998;81:288–292.
Young GP, Green TR. The role of single ECG, creatine kinase, and CK-MB in diagnosing patients with acute chest pain. Am J Emerg Med1993;11:444–449.
Marin MM, Teichman SL. Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain. Am Heart J1992;123:354–361.
Farkouh ME, Smars PA, Reeder GS, et al. A clinical trial of a chest pain observation unit for patients with unstable angina. CHEER investigators. N Engl J Med1998;339:1882–1888.
Lee TH, Ting HH, Shammash JB, Soukup JR, Goldman L. Long-term survival of emergency department patients with acute chest pain. Am J Cardiol1992;69:145–151.
Thomas EJ, Burstin HR, O'Neil AC, et al. Patient noncompliance with medical advice after the emergency department visit. Annals of Emergency Medicine1996;27:49–55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fleischmann, K.E., Goldman, L., Johnson, P.A. et al. Critical Pathways for Patients with Acute Chest Pain at Low Risk. J Thromb Thrombolysis 13, 89–96 (2002). https://doi.org/10.1023/A:1016246814235
Issue Date:
DOI: https://doi.org/10.1023/A:1016246814235